Shares plunged 6.8% to $488.21 Tuesday morning after Northrop Grumman delivered a second-quarter report that looked strong on the surface — record demand, bigger sales, higher earnings forecasts — but exposed a margin squeeze that spooked Wall Street. The sell-off raises a pointed question: Can the largest stealth-bomber maker translate a mountain of orders into actual profit growth?
The Numbers Beat, but the Profit Picture Didn't
Northrop reported $7.68 earnings per share, beating the consensus estimate of $6.84 by $0.84.
Revenue of $10.88 billion also topped the $10.80 billion forecast. Yet operating income fell 23% year-over-year, and the operating margin rate dropped to 10.1% from 13.8% — a gap partly explained by last year's one-time gain from a business sale, but also by $61 million of lower segment operating income. Investors are asking whether growing revenue without growing profits is a sustainable path.
A Record $105 Billion Backlog Sounds Great — Until You Price the Risk
Net awards of $20 billion pushed the backlog to a company record of $105 billion. That is roughly 2.4 years of revenue at current run rates, providing exceptional long-term visibility. But the Sentinel nuclear-missile program remains Northrop's biggest execution risk, and fixed-price development contracts like Sentinel have already burned investors with cost overruns. A giant backlog only matters if the work is profitable.
Raised Guidance Wasn't Enough to Calm the Street
Full-year sales guidance was lifted to $43.75–$44.25 billion (up $250 million), and adjusted EPS guidance rose to $28.60–$29.10 (up $1.20). However, the company reaffirmed — rather than raised — its operating income and free cash flow outlook, signaling that the extra revenue may not fall to the bottom line. Capital spending is running at $1.85 billion in 2026 to expand production capacity, further pressuring near-term cash returns.
Analysts Were Already Losing Patience
TD Cowen recently cut its price target from $680 to $580, and Goldman Sachs trimmed its target to $533.
At a price-to-earnings ratio around 19 and a free-cash-flow yield of roughly 4%, the stock needs steady margin improvement to justify any upside. Today's report didn't deliver that proof, and the market is punishing the gap between Northrop's revenue story and its profit reality.